TLRY
Recent Headlines
- The Week In Cannabis: Brazil Regulates Sales, Michigan Starts Adult Sales, Lil Wayne Goes Green, Federal Agencies Move Forward
- Hedge Funds Love Lattice Semiconductor (LSCC) Way More Than These Stocks
- Cannabis Industry Introduction
- Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?
- What You Need To Know About The International Cannabis Business Awards In Las Vegas
- Cannabis 2.0 Highlights the Rewards — and Risks — of Canopy Growth Stock
- Decade in Review: Assessing the impact of America’s opioid crisis
- Is It Too Early to Play the Cannabis Sector With KERN Stock?
- Hedge Funds Love The Chemours Company (CC) Way More Than These 3 Stocks
- Tilray® Expands Global Leadership Team With New Manitoba Harvest President
- Cannabis stocks fall for third straight day as market digests last of a weak batch of quarterly earnings
- Inner Spirit Holdings to Put Primary Focus on Spiritleaf Brand and Become Pure-Play Recreational Cannabis Retailer
- ‘CBD has the potential to harm you,’ FDA warns consumers
- Cannabis stocks rocked as FDA warning undermines case for CBD investments
- Seaport Updates Estimates for 3 Sinking Cannabis Stocks
- FDA expresses ‘safety concerns’ over CBD products
- Cronos Stock Gets Closer to Being a Buy, but It’s Not There Yet
- Marijuana Stocks Are Tumbling — Are Any Good Buys Right Now?
- Marijuana Stocks Fall As FDA Warns Of CBD Risk
- FDA warns ‘CBD has the potential to harm you’
- Is Aurora Cannabis Stock Officially Back from the Dead?
- Marijuana Stocks Are Slumping After the FDA Says CBD Could ‘Harm You’
- FDA updates stance on CBD, pot stocks dip
- Tilray Analyst's Conversation With CFO Builds Faith In Positive Catalysts
- Marijuana stocks get a lift, Edible Arrangements looks to CBD
- Canopy Growth Stock: Is the Worst Really Over?
- Remaining Resilient Amid Trade Uncertainty
- Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session
- Don’t Buy Cronos Stock on the U.S. House Committee Vote
- Marijuana ETFs Bounce Back: Can the Rally Last?
- Don’t Buy Tilray Stock Despite the Cannabis Rebound
- Tilray® Supports New Clinical Trial Evaluating the Efficacy of Medical Cannabis in Disorders Caused by Breast Cancer Treatment
- Cannabis Investment Manager: Canadian Woes Are Hurting US Stocks
- 10 Hot Pot Stocks to Buy
- Shareholders Worry as Tilray Stock Approaches IPO Price
- E-Cigarette Ban in New York: Impact on Cannabis Sector
- Pot stocks ‘significantly oversold’: ETF manager
- Cannabis stocks ‘significantly oversold’: ETF manager
- Investors Beware: Tilray Stock Might Not Be Done Dropping
- Why Did HEXO Rise 17% on Thursday?
- Hedge Funds Have Never Been This Bullish On Tilray, Inc. (TLRY)
- Celebrating the anniversary of marijuana legalization in Canada...but what's to come?
- Kiaro Signs Investment and Collaboration Agreement with High Park
- Charlotte’s Web Holdings: Analysts’ Target Price and Ratings
- High Park™ Unveils Comprehensive Portfolio of New Brands and Products for the Next Phase of Adult-Use Cannabis in Canada
- Cannabis Edibles: October 17 Is Almost Here!
- Plunging Tilray Stock Shows Just How Much Sentiment Has Changed
- There Probably Is a Lot More Bad News Ahead for Cronos Stock
- Cannabis Corruption in the US: Trouble before Elections?
- Aphria Q1 Earnings: A Ray of Hope for Cannabis?